Ambulatory IPF Clinical Trial Using Rituximab and Placebo

- The folks at University of Pittsburgh are studying the effects of Rituximab; Placebo on Ambulatory IPF in individuals ages 50 years to 85 years. This clinical trial is slated to start January 2014 and is expected to end circa October 2018.

412-692-2210
Steven R Duncan, MD
Overall Study Contact Info
StatusName Contact Phone
RecruitingSteven R Duncan, MDduncsr@upmc.edu412-692-2210

This study is officially titled, "Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis (ART-IPF)."

Locations

University of Chicago

Chicago, Illinois - Not yet recruiting

Geisinger Medical Center

Danville, Pennsylvania - Not yet recruiting

Temple University

Philadelphia, Pennsylvania - Not yet recruiting

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.